Tuesday, April 21, 2026

$100M Offers? OpenAI Staff Said ‘No Thanks’ to Meta’s Big Money

Sam Altman reveals Meta's failed attempts to recruit OpenAI talent despite offers of up to $100 million, highlighting corporate culture issues.

North Korea’s Agricultural Transformation: How the New Aedo Tidal Flat is Shaping the Future

North Korea completed the Aedo tidal flat construction, aiming to enhance agriculture and living standards, as reported by Rodong Sinmun.

Kim Jong Un Visits Munitions Plants, Demands Massive Artillery Boost

Kim Jong Un inspects military facilities to boost artillery shell production, emphasizing modernization and patriotism in North Korea.

Tag: Biotech

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

Celltrion’s Groundbreaking Achievement: First Asian Bio Company to Secure APEC CBPR and Global CBPR Certifications

Celltrion becomes the first South Korean biotech firm to earn APEC CBPR and Global CBPR certifications, enhancing global data protection.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

South Korea’s Pharmaceutical Future: 500 Million USD Investment from Eli Lilly to Boost K-Bio Innovation

South Korea partners with Eli Lilly to boost biotech and pharma industries, investing $500M to enhance innovation and healthcare access.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Unlocking Opportunities: Highlights from the 2026 J.P. Morgan Healthcare Conference in San Francisco

The 44th JP Morgan Healthcare Conference in San Francisco drew a large crowd of professionals in formal attire early in the morning.

Samsung Biologics Targets Japan’s $12.3 Billion CDMO Market: What You Need to Know

Samsung Biologics expands in Japan, targeting top pharma firms with new CMO brand 'ExellenS' and enhancing production capabilities.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

No More Lab Rats? FDA Shift Spurs AI Boom in Drug Development

AI is transforming drug discovery in pharma, especially after the FDA's shift away from animal testing, enhancing efficiency.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.